Chief Operating Officer @ Elusys Therapeutics, A subsidiary of NightHawk Biosciences (January 2022 - January 2023)
Senior Vice-President, Product Development and Portfolio Strategy @ NightHawk Biosciences, Inc (January 2021 - January 2023)
Vice President US Medical Affairs Biosimilars @ (January 2020 - January 2021)
Vice President, Oncology US Medical Affairs @ (January 2017 - January 2020)
Therapeutic Area Lead, Biotherapeutics and Gastroenterology, US Medical Affairs @ (January 2014 - January 2017)
Senior Director @ (January 2009 - January 2014)
Managing Director @ Kolabri Consulting, LLC (January 2008 - January 2009)
Director of Marketing @ (January 2003 - January 2008)
Product Manager @ (January 1995 - January 2002)
Paul Tebbey Education
Rochester Institute of Technology
MBA (Marketing)
East Carolina University
Ph.D. (Microbiology & Immunology)
University of the West of England
B.Sc. (Applied Biologic Sciences)
Paul Tebbey Skills
Biologics
Biopharmaceuticals
Biotechnology
Business Analysis
Clinical Trials
Commercialization
Cross-functional Team Leadership
Dermatology
Gastroenterology
Global Marketing
Immunology
International Marketing
Market Access
Marketing
Neurology
Pharmaceutical Industry
Product Development
Product Launch
Product Management
Product Marketing
Rheumatology
Start-ups
Vaccines
Public Speaking
Sales
Start Ups
Medicine
Microsoft Excel
Cross Functional Team Leadership
Marketing Strategy
Hospitals
Paul Tebbey Summary
Paul Tebbey, based in Chicago, IL, US, is currently a Chief Operating Officer at Direct Biologics. Paul Tebbey brings experience from previous roles at Radyus R&D, Elusys Therapeutics, A subsidiary of NightHawk Biosciences, NightHawk Biosciences, Inc and Fresenius Kabi USA. Paul Tebbey holds a MBA in Marketing @ Rochester Institute of Technology. With a robust skill set that includes Biologics, Biopharmaceuticals, Biotechnology, Business Analysis, Clinical Trials and more. Paul Tebbey has 2 emails and 6 mobile phone numbers on RocketReach.
Looking for a different Paul Tebbey?
Find contact details for 700 million professionals.